2011
DOI: 10.1039/c1mb05020f
|View full text |Cite
|
Sign up to set email alerts
|

N-linked glycan changes of serum haptoglobin β chain in liver disease patients

Abstract: Human haptoglobin is a serum glycoprotein secreted by the liver with four potential N-glycosylation sites on its β chain. Many studies have reported glycan changes of haptoglobin in diseases such as breast cancer and pancreatic cancer. The objective of our study is to analyze N-linked glycan alterations of serum haptoglobin β chain obtained from patients with the hepatitis B virus (HBV), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). MALDI-QIT-TOF mass spectrometry revealed the intensity of m/z 1809.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
49
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(53 citation statements)
references
References 31 publications
4
49
0
Order By: Relevance
“…Altered glycosylation of plasma proteins is a common finding associated with liver diseases, including cirrhosis, cancer and hepatitis [26,[28][29][30][31][32][33][34]. An increase in branching and fucosylation of transferrin N-glycans has previously been reported in patients with hepatocellular carcinoma [26,32,34], which was similar to the pattern found in the samples with di-tri bridging.…”
Section: Discussionsupporting
confidence: 53%
“…Altered glycosylation of plasma proteins is a common finding associated with liver diseases, including cirrhosis, cancer and hepatitis [26,[28][29][30][31][32][33][34]. An increase in branching and fucosylation of transferrin N-glycans has previously been reported in patients with hepatocellular carcinoma [26,32,34], which was similar to the pattern found in the samples with di-tri bridging.…”
Section: Discussionsupporting
confidence: 53%
“…In the case of HCT116 cells, cancer cells themselves cannot produce Fuc-Hpt, indicating that their surrounding normal cells such as hepatocytes and lymphocytes produced Fuc-Hpt. After we reported that Fuc-Hpt is a promising biomarker for pancreatic cancer, many researchers have reported increases in Fuc-Hpt in sera of patients with different cancers such as colon cancer [24], liver cancer [25], lung cancer [26], and pancreatic cancer [27]. …”
Section: Fucosylated Haptoglobinmentioning
confidence: 99%
“…10,11 Haptoglobin is one of the acute phase proteins (APP) secreted by the liver, which binds to hemoglobin and plays an important role in response to inflammation and malignancy. 12 It consists of β, α-1, and α-2 chains, with four potential N -glycosylation sites on its β chain.…”
Section: Introductionmentioning
confidence: 99%
“…10,11,18 A MALDI-QIT-TOF analysis of N -glycans of serum Hp revealed that a biantennary fucosylated glycan was highly increased in patients with cirrhosis and HCC compared to healthy controls. 11 Recently, a quantitative liquid chromatography–mass spectrometry multiple reaction monitoring analysis of site-specific glycoforms of Hp showed that multiply fucosylated glycoforms increased significantly in the liver disease group compared to that in healthy controls. 18 However, in these studies, mass spectrometric analyses of haptoglobin glycans were performed using either pooled sera or a limited number of cases of liver diseases.…”
Section: Introductionmentioning
confidence: 99%